Mark L. Alley
Algemeen Directeur bij Cipher Surgical Ltd.
Profiel
Mark L.
Alley is currently the Chief Executive Officer at Cipher Surgical Ltd.
He previously worked as the Vice President-Sales at Intersect ENT, Inc. from 2021 to 2022.
Actieve functies van Mark L. Alley
| Bedrijven | Functie | Begin |
|---|---|---|
Cipher Surgical Ltd.
 Cipher Surgical Ltd. Medical SpecialtiesHealth Technology Cipher Surgical Ltd. designs and develops laparoscopic medical devices. It offers OpClear, which is a sterile disposable unit that provides intra-abdominal solution for distal window contamination for the entire laparoscopic procedure. The company was founded by Andrew Newell, Simon Timothy James Ratcliffe and Neil Roderick Walmsley on May 18, 2010 and is headquartered in Coventry, the United Kingdom. | Algemeen Directeur | 04-03-2024 |
Eerdere bekende functies van Mark L. Alley
| Bedrijven | Functie | Einde |
|---|---|---|
| INTERSECT ENT, INC. | Verkoop & Marketing | 01-05-2022 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
Cipher Surgical Ltd.
Cipher Surgical Ltd. Medical SpecialtiesHealth Technology Cipher Surgical Ltd. designs and develops laparoscopic medical devices. It offers OpClear, which is a sterile disposable unit that provides intra-abdominal solution for distal window contamination for the entire laparoscopic procedure. The company was founded by Andrew Newell, Simon Timothy James Ratcliffe and Neil Roderick Walmsley on May 18, 2010 and is headquartered in Coventry, the United Kingdom. | Health Technology |
